B.GRIMM Pharma participated in the 23rd Mastering the Case-Based Approach in Rheumatology for Non-Rheumatologists at Phramongkutklao Hospital, supporting the lecture on “Febuxostat in High-Risk Gout Patients: Cardiovascular Safety, Treat-to-Target, and Beyond” delivered by Assoc. Prof. Wanruchada Katchamart, Faculty of Medicine, Siriraj Hospital. The session provided updates from the research and shared clinical perspectives on gout management, contributing to knowledge exchange among healthcare professionals.
At B.GRIMM Pharma, we are committed to building a healthier society by ensuring access to high-quality healthcare products, advancing innovations that address evolving health needs, and advancing scientific collaboration to deliver impactful solutions for the well-being of all.
